• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Voice Preservation

Making Our Voices Heard

Speech is a key part of a person’s identity. Voice matters to personal identity and expression, and connection with family and friends. The majority of people living with ALS/MND are eventually robbed of this fundamental part of their humanity.

This can be overcome using voice preservation technologies, but our research shows this is not equitably accessible. The Alliance seeks to provide universal access to technology to improve the quality of life of people living with ALS/MND. The ideal for every individual living with ALS/MND worldwide is to have the right to access voice preservation upon diagnosis.

The Voice Preservation Project

The Alliance, through a collaboration between Hospital Universitario Nacional de Colombia (HUN) and the Asociación Colombiana de ELA (ACELA), has launched a pilot project to deliver voice preservation technology to people living with ALS/MND in Colombia. This will serve as the basis on which future plans will be made on how best to scale to reach more people around the world.

If you would like to join us in expanding our reach to more people, please donate. We deeply appreciate your support.

Watch this video to find out more from the Alliance and its Information Technology Advisory Council (ITAC).

https://www.als-mnd.org/wp-content/uploads/2023/06/Voice-Preservation-ITAC-Intro.mp4

Watch this video to hear from Orlando Ruiz, founder of ACELA and a person living with ALS/MND, as he emphasizes the devastation of losing your voice. He goes on to explain the potential of voice banking technology to preserve dignity, autonomy and identity, and ensure no one loses their voice to ALS/MND.

 

Keep Up To Date

This project is in development and more details and information are coming soon! If you are interested in learning more, sign up to get periodic updates as the work progresses.

Subscribe

* indicates required
 
 

 

Disclaimer: Voice preservation is not designed, intended or made available for diagnosis, treatment or prevention of diseases or for use as a medical device. It is also not designed or intended to replace or be a substitute for professional medical advice, diagnosis, treatment or judgment.

Primary Sidebar

  • JP

    JP

  • Elkin Ramiro Gaviria Muñoz, Colombia

    Elkin Ramiro Gaviria Muñoz, Colombia

  • Steve Lufkin, USA

    Steve Lufkin, USA
    IMG_3993

  • Imelda Arenas, Colombia

    Imelda Arenas, Colombia

  • Charlie Dourney, USA

    Charlie Dourney, USA

  • Phil Rossall, UK

    Phil Rossall, UK

  • Ana María Zavala, Mexico

    Ana María Zavala, Mexico

  • Carlos Alberto Báez Murillo, Colombia

    Carlos Alberto Báez Murillo, Colombia

  • Sébastien Batiot, France

    Sébastien Batiot, France

  • Fernando Ocampo Cardona, Colombia

    Fernando Ocampo Cardona, Colombia

  • Malu Araujo Ribeiro, Brazil

    Malu Araujo Ribeiro, Brazil

  • Chen Chun-Chin, Malaysia

    Chen Chun-Chin, Malaysia

  • David Bishop, UK

    David Bishop, UK

  • David Hall, USA

    David Hall, USA

  • PALS and CALS, Singapore

    PALS and CALS, Singapore

  • Claudia Gotti, Brazil

    Claudia Gotti, Brazil

  • Paul Launer, USA

    Paul Launer, USA

  • Danny Reviers, Belgium

    Danny Reviers, Belgium

  • Mauricio Dorin, Argentina

    Mauricio Dorin, Argentina

  • Fabio Carvalho, Brazil

    Fabio Carvalho, Brazil

  • Hollister

    Hollister
    hollister

  • Lachlan Terry, Australia

    Lachlan Terry, Australia

  • Lucy Lintott, Scotland

    Lucy Lintott, Scotland

  • Roxana Canova, Argentina

    Roxana Canova, Argentina

  • Dan Doctoroff, USA

    Dan Doctoroff, USA

  • Mauril Bélanger, Canada

    Mauril Bélanger, Canada

  • Yolanda Armendariz, Mexico

    Yolanda Armendariz, Mexico

  • Mahmood Anwar, UK

    Mahmood Anwar, UK

  • Christian Bär, Germany

    Christian Bär, Germany

  • Frank Taylor, USA

    Frank Taylor, USA

  • Orly Dichoso, Canada

    Orly Dichoso, Canada

  • Joyce Rusinak, USA

    Joyce Rusinak, USA

  • Animesh Kumar, India

    Animesh Kumar, India

  • Jose Espinosa, Argentina

    Jose Espinosa, Argentina

  • Claire Garry, USA

    Claire Garry, USA
    20200117_214643

  • Brigitte Wernli, Switzerland

    Brigitte Wernli, Switzerland

  • Chun Ju Xiao, China

    Chun Ju Xiao, China

  • Rob Tison, USA

    Rob Tison, USA

  • Joanne Pratt, Australia

    Joanne Pratt, Australia

  • Cath Muir, UK

    Cath Muir, UK
    Cath

  • Maria Lucia Wood Saldanha, Brazil

    Maria Lucia Wood Saldanha, Brazil

  • Eric Von Schaumburg, USA

    Eric Von Schaumburg, USA

  • Brian Lovell, Australia

    Brian Lovell, Australia

  • Catherine Pearce, Australia

    Catherine Pearce, Australia

  • Claudette Sturk, Canada

    Claudette Sturk, Canada
    Picture2

  • Joyce Rusinak, USA

    Joyce Rusinak, USA

  • Jose Rivero Muñoz, Mexico

    Jose Rivero Muñoz, Mexico

  • Xian-Zhang Niu, China

    Xian-Zhang Niu, China

  • Mary Thomas, Australia

    Mary Thomas, Australia

  • Dr. Janmejay Pradhan, India

    Dr. Janmejay Pradhan, India

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login